- Home
- ICCC vs ELTK Comparison
ICCC vs ELTK Comparison
Compare ICCC & ELTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCC
- ELTK
- Stock Information
- Founded
- ICCC 1982
- ELTK 1970
- Country
- ICCC United States
- ELTK Israel
- Employees
- ICCC N/A
- ELTK N/A
- Industry
- ICCC Biotechnology: Pharmaceutical Preparations
- ELTK Electrical Products
- Sector
- ICCC Health Care
- ELTK Technology
- Exchange
- ICCC Nasdaq
- ELTK Nasdaq
- Market Cap
- ICCC 48.3M
- ELTK 57.5M
- IPO Year
- ICCC 1987
- ELTK 1997
- Fundamental
- Price
- ICCC $5.50
- ELTK $8.53
- Analyst Decision
- ICCC
- ELTK
- Analyst Count
- ICCC 0
- ELTK 0
- Target Price
- ICCC N/A
- ELTK N/A
- AVG Volume (30 Days)
- ICCC 39.3K
- ELTK 8.1K
- Earning Date
- ICCC 05-14-2025
- ELTK 05-20-2025
- Dividend Yield
- ICCC N/A
- ELTK 2.23%
- EPS Growth
- ICCC N/A
- ELTK N/A
- EPS
- ICCC N/A
- ELTK 0.63
- Revenue
- ICCC $26,493,169.00
- ELTK $46,527,000.00
- Revenue This Year
- ICCC N/A
- ELTK $18.60
- Revenue Next Year
- ICCC N/A
- ELTK $9.04
- P/E Ratio
- ICCC N/A
- ELTK $13.54
- Revenue Growth
- ICCC 51.63
- ELTK N/A
- 52 Week Low
- ICCC $3.34
- ELTK $7.65
- 52 Week High
- ICCC $5.82
- ELTK $12.47
- Technical
- Relative Strength Index (RSI)
- ICCC 59.13
- ELTK 45.32
- Support Level
- ICCC $4.63
- ELTK $8.39
- Resistance Level
- ICCC $5.72
- ELTK $8.71
- Average True Range (ATR)
- ICCC 0.42
- ELTK 0.32
- MACD
- ICCC 0.05
- ELTK 0.14
- Stochastic Oscillator
- ICCC 79.82
- ELTK 83.02
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
About ELTK Eltek Ltd.
Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. It manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnects. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. Its geographic areas are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.